Evaluating the patients with thalassemia major for long-term endocrinological complications after bone marrow transplantation.
The aim of this study was to evaluate the endocrinological complications of the patients with thalassemia major (TM) who underwent bone marrow transplantation (BMT) and followed-up more than two years in our center, prospectively. "BMT group" consisted of 41 patients with TM. The mean age was 12.4 ± 5.4 years and transplantation age was mean 7.5 ± 4.9 years. Post-BMT follow-up lasted from 24 to 122 months (mean 65.07 months). Also, 32 TM patients with similar age group and same history of transfusion and chelation therapy were recruited for the study as "control (C) group". The weight SDS score after transplantation was found better than before transplantation (p = 0.010). There was a negative correlation between height SDS and BMT age (p = 0.008). The height SDS scores were better in patients whose BMT age was under seven years old compared to those older than seven years old (p = 0.02). Z-scores of femur neck and L2-4 vertebrae DEXA were decreased (p = 0.032, p = 0.0001) and incidence of insulin resistance increased (p = 0.01) in patients with increased BMT age. The risk of gonadal insufficiency was significantly lower in the patients who underwent BMT <7 years of age (p = 0.009). There was no statistically significant relationship between BMT age and complications such as hypothyroidism, hypoparathyroidism, and adrenal insufficiency. The patients with TM should be evaluated for transplantation in early stage of the disease, especially before the age of seven years. Because the BMT cannot correct the endocrinological complications of TM completely, the patients should be followed up regularly after the transplantation.
1Department of Pediatrics, Akdeniz University School of Medicine, Antalya, Turkey.
Bilge
B
Aldemir-Kocabaş
Gülsün
G
Tezcan-Karasu
Iffet
I
Bircan
Oğuz
O
Bircan
Anıl
A
Aktaş-Samur
Mehmet Akif
MA
Yeşilipek
D000293:Adolescent; D000367:Age Factors; D015519:Bone Density; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D002648:Child; D004700:Endocrine System Diseases / Q000209:etiology*; D005260:Female; D006058:Gonadal Disorders / Q000209:etiology; D006801:Humans; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D008297:Male; D017086:beta-Thalassemia / Q000150:complications* / Q000628:therapy
D007334:Insulin-Like Growth Factor I
age of transplantation; bone marrow transplantation; endocrinological complications; thalassemia Major